May 16, 2013 We Don’t Have To Give Up Our Place To Special Interests: Democracy Gives Us Options Celia Wexler Former contributor
April 11, 2013 Its Master's Voice: The FDA's Dependence on Drug Industry Fees Margaret Mellon Former contributor
April 5, 2013 Following Science, Judge Orders Over-the-Counter Access to Emergency Contraception drug Plan B Michael Halpern Former Contributor
March 14, 2013 Freedom to Tweet: Grading Social Media Policies in the Federal Government Michael Halpern Former Contributor
February 25, 2013 Weaker Antibiotic Regulation: Another Problem with FDA's Voluntary Cooperation Program Margaret Mellon Former contributor
February 20, 2013 Putting the Interests of Patients First: Conference Endorses Science-Focused Health Care Celia Wexler Former contributor
February 1, 2013 Negotiating with Drug Companies: The Horse-Trading Behind the FDA's Voluntary Program Margaret Mellon Former contributor
January 11, 2013 FDA Gets it Right as Merck Suspends Sales of Cholesterol Drug Tredaptive Michael Halpern Former Contributor
December 7, 2012 Fixing an Obama Administration Mistake on Emergency Contraception and Science Michael Halpern Former Contributor
November 13, 2012 Congress Does Something Right — For Federal Scientists Celia Wexler Former contributor
June 29, 2012 The Future Health of Scientific Integrity is at Stake in New FDA Law Celia Wexler Former contributor
June 5, 2012 New Report Details What Should Happen When Scientists at FDA Disagree Francesca Grifo Former contributor
May 24, 2012 For Sara, Faulty Medical Device Leads to Unnecessary, Invasive Surgery Michael Halpern Former Contributor
May 18, 2012 Study: FDA is Faster than Europe, Canada in Drug Approvals Michael Halpern Former Contributor
May 10, 2012 Senate Does the Right Thing for Whistleblowers – So Close to a Win-Win-Win Celia Wexler Former contributor
May 2, 2012 New Executive Order Could Limit Ability of U.S. Science Agencies to Protect the Public Celia Wexler Former contributor
April 25, 2012 The Human Cost of FDA Decisions: A Faulty Hip Replacement Disrupts a Young Man's Life Michael Halpern Former Contributor
April 13, 2012 How Conflicted Experts Can Sway FDA Drug Approval Decisions: A Case Study on Yaz Francesca Grifo Former contributor
April 11, 2012 The Human Cost of FDA Decisions: For Dan and Elsa, Life Depends on Safe Medical Devices Michael Halpern Former Contributor
